Syneron Medical Ltd. (ELOS)
-NasdaqGS 8.87 
0.03(0.34%) May 21, 4:00PM EDT
| Prev Close: | 8.90 |
|---|
| Open: | 8.90 |
|---|
| Bid: | 7.28 x 200 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 17.00 |
|---|
| Beta: | 1.19 |
|---|
| Next Earnings Date: | 22-May-13 |
|---|
| Day's Range: | 8.84 - 8.98 |
|---|
| 52wk Range: | 7.21 - 11.15 |
|---|
| Volume: | 118,914 |
|---|
| Avg Vol (3m): | 119,061 |
|---|
| Market Cap: | 315.98M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.04 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Syneron Medical Earnings: Your Sneak Peek to the Big Announcementat Wall St. Cheat Sheet(Tue, May 21)
- Does The Street Have Syneron Medical Figured Out?at Motley Fool(Fri, May 17)
- Syneron Introduces Enhancements to its Innovative Body Shaping ProductsCNW Group(Thu, May 16)
- Syneron Introduces Enhancements to its Innovative Body Shaping ProductsPR Newswire(Thu, May 16)
- 2 Little Known, High Growth Companies Trading At Compelling Valuationsat Seeking Alpha(Mon, May 13)
- Syneron Medical Announces Syneron Beauty's Successful Launch of the me smooth and the Pearl Brilliant White SystemsPR Newswire(Thu, May 2)
- me smooth At-Home elos Professional Hair Removal System Debuts on QVCPR Newswire(Thu, Apr 25)
- ClickSoftware Bets Phones to Lift Sales: Israel Overnightat Bloomberg(Thu, Apr 25)
- Manhattan Lures Gazit as Web Shops Grow: Israel Overnightat Bloomberg(Tue, Apr 23)
- Tech Revenue Dwindles as EZchip Tumbles: Israel Overnightat Bloomberg(Sun, Apr 21)
- Syneron Medical to Report First Quarter 2013 Financial Results on May 22, 2013PR Newswire(Thu, Apr 18)
- Syneron Medical Names New CEOat Motley Fool(Wed, Apr 17)
- Syneron Medical's CEO Presents at Management Transition Conference Call (Transcript)at Seeking Alpha(Wed, Apr 17)
- Syneron co-founder Eckhouse tapped to replace CEOAP(Wed, Apr 17)
- Syneron Medical Appoints Co-Founder and Chairman of the Board Shimon Eckhouse to Chief Executive OfficerPR Newswire(Wed, Apr 17)
Key Statistics
| Forward P/E (1 yr): | 10.69 |
|---|
| P/S (ttm): | 1.20 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.47 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.02 |
|---|
| Mean Recommendation*: | 1.5 |
|---|
| PEG Ratio (5 yr expected): | 0.52 |
|---|
Business Summary
Syneron Medical Ltd., together with its subsidiaries, engages in the research, manufacture, development, marketing, and sale of aesthetic medical products worldwide.
View More